Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M E Davis

Showing results (51-60 of 348) with videos related to

Pageof 35
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 8, 2017
Proton Pump Inhibitors, Nephropathy, and Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes StudyTimothy M E Davis, Jocelyn Drinkwater, Wendy A Davis
Internal Medicine Journal|January 15, 2024
Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase IITimothy M E Davis, Kirsten E Peters, Wendy Davis
Diabetes Care|October 27, 2006
A clinical screening tool identifies autoimmune diabetes in adults: response to Fourlanos et alTimothy M E Davis, Carole A Cull, Rury R Holman
The Journal of Clinical Endocrinology and Metabolism|May 1, 2020
Temporal Trends in Cardiovascular Complications in People With or Without Type 2 Diabetes: The Fremantle Diabetes StudyWendy A Davis, Edward W Gregg, Timothy M E Davis
Antimicrobial Agents and Chemotherapy|May 27, 2005
Effects of a high-fat meal on the relative oral bioavailability of piperaquineIng-Kye Sim, Timothy M E Davis, Kenneth F Ilett
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 12, 2003
Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detectionTe-Yu Hung, Timothy M E Davis, Kenneth F Ilett
Diabetes Care|September 28, 2005
Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes: the Fremantle Diabetes StudyDavid G Bruce, Wendy A Davis, Timothy M E Davis
Circulation|January 31, 2013
Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79Timothy M E Davis, Ruth L Coleman, Rury R Holman, et al.
International Journal of Epidemiology|May 1, 2012
Cohort profile: the Fremantle Diabetes StudyTimothy M E Davis, David G Bruce, Wendy A Davis
Journal of Diabetes and Its Complications|March 4, 2020
Incidence and predictors of vision loss complicating type 2 diabetes: The Fremantle Diabetes Study Phase IIJocelyn J Drinkwater, Timothy M E Davis, Wendy A Davis
Pageof 35

Showing results (51-60 of 348) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Endocrinology and Metabolism|June 8, 2017
Proton Pump Inhibitors, Nephropathy, and Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes StudyTimothy M E Davis, Jocelyn Drinkwater, Wendy A Davis
Internal Medicine Journal|January 15, 2024
Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase IITimothy M E Davis, Kirsten E Peters, Wendy Davis
Diabetes Care|October 27, 2006
A clinical screening tool identifies autoimmune diabetes in adults: response to Fourlanos et alTimothy M E Davis, Carole A Cull, Rury R Holman
The Journal of Clinical Endocrinology and Metabolism|May 1, 2020
Temporal Trends in Cardiovascular Complications in People With or Without Type 2 Diabetes: The Fremantle Diabetes StudyWendy A Davis, Edward W Gregg, Timothy M E Davis
Antimicrobial Agents and Chemotherapy|May 27, 2005
Effects of a high-fat meal on the relative oral bioavailability of piperaquineIng-Kye Sim, Timothy M E Davis, Kenneth F Ilett
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 12, 2003
Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detectionTe-Yu Hung, Timothy M E Davis, Kenneth F Ilett
Diabetes Care|September 28, 2005
Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes: the Fremantle Diabetes StudyDavid G Bruce, Wendy A Davis, Timothy M E Davis
Circulation|January 31, 2013
Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79Timothy M E Davis, Ruth L Coleman, Rury R Holman, et al.
International Journal of Epidemiology|May 1, 2012
Cohort profile: the Fremantle Diabetes StudyTimothy M E Davis, David G Bruce, Wendy A Davis
Journal of Diabetes and Its Complications|March 4, 2020
Incidence and predictors of vision loss complicating type 2 diabetes: The Fremantle Diabetes Study Phase IIJocelyn J Drinkwater, Timothy M E Davis, Wendy A Davis
Pageof 35